Sex Transm Dis by Jones, Jeb et al.
Proportion of Incident HIV Cases among Men Who Have Sex 
with Men Attributable to Gonorrhea and Chlamydia: A Modeling 
Analysis
Jeb Jones, PhD, MPH, MSa, Kevin Weiss, MPHa, Jonathan Mermin, MDb, Patricia Dietz, 
DrPHb, Eli S. Rosenberg, PhDc, Thomas L. Gift, PhDb, Harrell Chesson, PhDb, Patrick S. 
Sullivan, DVM, PhDa, Cynthia Lyles, PhDb, Kyle T. Bernstein, PhDb, and Samuel M. Jenness, 
PhDa
aDepartment of Epidemiology, Emory University, Atlanta, Georgia
bCenters for Disease Control and Prevention, Atlanta, Georgia
cDepartment of Epidemiology and Biostatistics, University at Albany, Albany, New York
Abstract
Background—Sexually transmitted infections (STIs) are associated with an increased risk of 
HIV acquisition and transmission. We estimated the proportion of HIV incidence among men who 
have sex with men attributable to infection with the two most common bacterial STIs, Neisseria 
gonorrhoeae (NG) and Chlamydia trachomatis (CT).
Methods—We used a stochastic, agent-based model of a sexual network of MSM with co-
circulating HIV, NG, and CT infections. Relative risk (RR) multipliers, specific to anatomic site of 
infection, modified the risk of HIV transmission and acquisition based on STI status. We estimated 
the effect of NG and CT on HIV incidence overall and on HIV acquisition and HIV transmission 
separately. Each scenario was simulated for ten years. The population attributable fraction (PAF) 
was determined for each combination of RRs by comparing the incidence in the final year of a 
scenario to a scenario in which the RRs associated with NG and CT were set to 1.0.
Results—Overall, 10.4% (IQR: 7.9,12.4) of HIV infections were attributable to NG/CT 
infection. Then in sensitivity analyses, the PAF for HIV transmission ranged from 3.1% (IQR: 0.5, 
5.2) to 20.4% (IQR: 17.8, 22.5) and the PAF for HIV acquisition ranged from 2.0% (IQR: −0.7, 
4.3) to 13.8% (IQR: 11.7, 16.0).
Conclusions—Despite challenges in estimating the causal impact of NG/CT on HIV risk, 
modeling is an alternative approach to quantifying plausible ranges of effects given uncertainty in 
the biological co-factors. Our estimates represent idealized public health interventions in which 
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STI could be maximally prevented, setting targets for real-world STI interventions that seek to 
reduce HIV incidence.
Summary
Approximately 10% of incident HIV infections among MSM in the US are caused by prevalent 
gonorrhea or chlamydia infection.
Introduction
Biological plausibility for a causal relationship between STI and HIV incidence is strong1–8, 
however, the population-level effect of common STIs, including Chlamydia trachomatis 
(CT) and Neisseria gonorrhoeae (NG), on HIV incidence has been challenging to estimate. 
Further, most estimates have been obtained among heterosexual populations rather than men 
who have sex with men (MSM), with varying results from different studies.9,10 One 
challenge has been to separate the effects of NG/CT on HIV acquisition and transmission 
risks. NG/CT are thought to increase the risk of HIV acquisition by damaging the genital or 
rectal epithelium or by increasing the availability of HIV target cells in the genital or rectal 
tracts.11 Increased HIV transmission is thought to occur from increased viral shedding of 
HIV associated with prevalent NG/CT infection.11
Behavioral confounding may contribute to the observed association between prevalent STI 
and incident HIV. MSM with multiple sexual partners are more likely to be diagnosed with 
both HIV and STIs.12,13 Because transmission for both STIs and HIV occur across the same 
network of sexual partnerships, it is difficult to separate the confounding factor of increased 
behavioral risk factors from the direct causal effects that STIs have on HIV risk.14
In this study, we used agent-based modeling to estimate the population attributable fraction 
(PAF) of NG/CT infection on HIV incidence among MSM in the United States. This 
approach allows the simulation of synthetic populations to directly observe the causal effect 
of NG/CT without confounding biases that are inherent in empirical observational study 
designs. Despite uncertainty from empirical studies regarding the effect of NG/CT on HIV 
risk, previous modeling studies have used fixed effects to model the relationship. By 
modeling the co-circulation of HIV, CT, and NG in this population we tested a range of 
plausible values for the effect of NG and CT infections on HIV acquisition and transmission 
that could set targets for the maximal effects on HIV incidence that could be achieved by a 
STI prevention intervention. We estimated the proportion of incident HIV infections 
attributable to NG and CT infections by comparing incidence in scenarios in which NG/CT 
contributed to HIV risk to a scenario in which NG/CT had no effect on HIV risk.
Methods
In previous research, we developed a robust mathematical model for HIV/STI transmission 
dynamics for US MSM using the EpiModel software platform (www.epimodel.org).15 The 
EpiModel platform allows for simulating epidemics over dynamic sexual networks. The 
overall model structure, parameters, and outcomes are similar to Jenness et al.16 Networks 
are comprised of dyads representing anal sex partnerships that may be one-time sexual 
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encounters; casual, ongoing but shorter-duration partnerships; or main longer-duration 
partnerships. Predictors of partnership formation included age of partners, sexual role 
preferences, number of ongoing partnerships, and partner type. Behavioral components of 
the model were parameterized in part based on data from empirical sexual network studies 
conducted in Atlanta, Georgia.17,18 Sexual activity within extant partnerships, including 
sexual position and condom use, was simulated on a weekly time step. Condom use varied 
based on partnership type (main, casual, and one-time), HIV diagnosis, and HIV status 
disclosure within partnerships. Specific parameter values and model structure are described 
in detail in the Appendix (Sections 2–3).
HIV/STI Transmission and Disease Progression
Among partnerships that were discordant on HIV and/or STI status, transmission of HIV, 
NG, and CT occurred within simulated acts of anal intercourse. Probability of HIV 
transmission was modified by NG/CT infection (described in more detail below), viral load 
of the infected partner19, CCR5-delta 32 genetic allele status of the susceptible partner20, 
condom use21, sexual role22, and circumcision status of insertive partners.23 Following 
infection, HIV disease progressed through acute, chronic, and AIDS stages dependent on 
current ART treatment status. HIV viral load was simulated as a continuous function of time 
since infection, disease stage, and current ART status. NG and CT infection remained active 
until diagnosis and antibiotic treatment (average treatment duration = 7 days) or natural 
clearance (average duration = 246 and 310 days, respectively).
Effect of STI on HIV Transmission and Acquisition
Model parameters for relative risks (RRs) increased the per-act probability of transmission 
or acquisition of HIV conditional on prevalent NG/CT status. RRs were constant across the 
duration of NG/CT infection.
An overall PAF, combining the effects of STI on HIV acquisition and transmission, was 
calculated by comparing the scenario with RRs for which we have the strongest evidence to 
a scenario in which acquisition and transmission RRs were set to 1.0. The ‘strongest 
evidence’ RRs were the acquisition RRs from the base case scenario (rectal acquisition 
RR=1.97; urethral acquisition RR=1.48) and the transmission RRs were based on empirical 
evidence24 (rectal and urethral transmission RR=1.3).
We also conducted sensitivity analyses in order to obtain a plausible range for the effect of 
NG/CT on HIV transmission and acquisition risk in isolation. NG/CT RRs affected HIV 
transmission or acquisition based on anatomical site of infection and sexual role. RRs for 
HIV transmission applied if (1) the HIV-infected partner had urethral NG or CT and was 
insertive during the sexual act, or (2) the HIV-infected partner had rectal NG or CT and was 
receptive during the sexual act. Similarly, RRs for HIV acquisition applied if (1) the HIV-
uninfected partner had urethral NG or CT and was insertive during the sexual act, or (2) the 
HIV-uninfected partner had rectal NG or CT and was receptive during the sexual act.
We examined the effect of NG/CT on HIV incidence under a range of plausible RRs for HIV 
transmission and acquisition. Separate analyses were conducted to isolate the effects of HIV 
transmission versus HIV acquisition. To assess the potential impact of increased risk of HIV 
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acquisition due to NG/CT, acquisition RRs (Table 1) were varied while holding the 
transmission RR constant. In our previous applications, we only modeled the RR for each 
STI on HIV acquisition, with no increased risk for HIV transmission associated with 
prevalent STI.16 To account for the effect of HIV transmission in the acquisition RR 
scenarios, a the ‘best evidence’ value RR of 1.3 was used for the effect of NG and CT 
infection on HIV transmission based on data obtained in an African cohort study.24 No 
estimates of a transmission RR, as defined above, exist for MSM populations.
To assess the potential impact of increased risk of HIV transmission, transmission RRs were 
varied in separate models (Table 1), holding acquisition RR constant. Acquisition RRs were 
held constant at the levels that the base case of the model is calibrated to (rectal infection 
RR=1.97; urethral infection RR=1.48).
Estimates are not available for the effect of NG/CT co-infection. Thus, we conducted a 
sensitivity analysis evaluating two plausible biological mechanisms: 1) the highest RR from 
NG or CT prevailed; or 2) the co-infection RR was the product of the individual NG and CT 
RRs. We observed no clinically meaningful differences between these two scenarios. Results 
under the scenario that the highest RR prevailed are presented below; results under the 
multiplicative assumption are presented in the Appendix.
Model Scenarios
Burn-in simulations were conducted to calibrate the model to observed HIV prevalence 
(15%25) and NG/CT incidence (3.526,27 and 5.626 incident infections/100 person-years, 
respectively). NC/CT incidence included both symptomatic and asymptomatic infections. 
Burn-in simulations were generated using the base-case HIV acquisition RRs, which were 
estimated for the acquisition RRs and fixed for the transmission RRs. Experimental 
scenarios for each combination of relative risks were simulated 256 times for 10 years each 
using the same starting burn-in simulation.
Measures
Outcomes were estimated using the final year of the 10-year follow-up. The incidence rate 
per 100 PYAR was determined for each scenario in that interval. The PAF of NG/CT on HIV 
incidence was defined as:
PAF =  
IRi −  IRre f
IRi
where IRi is a scenario with specified RRs and IRref is the scenario with null RRs (i.e., RR = 
1.0). To calculate the PAF for HIV acquisition attributable to NG/CT, the scenario in which 
all acquisition relative risks were set equal to 1.0 was the referent (IRref).
The relative frequency of sexual acts resulting in HIV transmission were quantified based on 
the anatomical site of exposure and the prevalent NG/CT status of the newly-infected 
partner. As with the determination of the PAFs, the proportions reflect incident NG/CT that 
were role- and site-specific. First, transmission events were categorized based on whether a 
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rectal and/or urethral NG/CT infection was present. STIs were only counted if present in a 
role-specific site that could contribute to infection (e.g., prevalent urethral NG/CT in an 
insertive partner). Second, transmission events were categorized based on the NG/CT status 
of the newly HIV-infected partner.
The median and IQR of the PAF were determined for the final year of each comparison 
scenario using the null as the reference. All analyses were conducted in R 3.4.3. Analysis 
scripts and simulation data can be accessed at https://github.com/EpiModel/sti_paf.
Results
The estimated prevalence of HIV, NG, and CT over the last year of the burn-in model, which 
provided the starting point for each of the scenarios modeled, was 14.7% (IQR: 14.3,15.1), 
1.3% (IQR: 0.9,1.5), and 3.7% (IQR: 3.3,4.1), respectively. Overall, considering the effects 
of NG/CT on HIV acquisition and transmission together, the PAF of NG/CT on HIV was 
10.2% (IQR: 7.9,12.4) when comparing the ‘best estimate’ scenario to the null-effects 
scenario.
The results of the sensitivity analysis examining the effect of increased HIV transmission 
due to NG/CT are presented in Table 2. Holding the effect of NG/CT on HIV acquisition 
constant, the incidence of HIV increased as the RRs of NG/CT on HIV transmission 
increased. In the scenario assuming NG/CT did not affect HIV transmission, estimated 
incidence across simulations was 1.90 infections/100 PYAR (IQR: 1.86,1.94). The highest 
incidence was observed in the scenario with the highest RRs for NG/CT on HIV 
transmission (2.39/100 PYAR; IQR: 2.31,2.45). The PAF increased as the RRs of NG/CT on 
HIV transmission increased. Observed PAFs ranged from median values of 3.1% (IQR: 
0.5,5.2) to 20.4% (IQR: 17.8,22.5).
The results of the sensitivity analysis examining the effect of increased HIV acquisition due 
to NG/CT are presented in Table 3. When NG/CT did not have an effect on HIV acquisition, 
the incidence rate was 1.83/100 PYAR (IQR: 1.78,1.87). The highest incidence rate was 
observed in the scenario with the highest RRs for NG/CT on HIV acquisition (2.12/100 
PYAR; IQR: 2.07,2.17). In the base case scenario, with relative risks reflecting previous 
empirical and modeling work, the incidence rate was 1.96/100 PYAR (IQR: 1.91,2.01). The 
PAF of STI on HIV acquisition ranged from a low of 2.0% (IQR: −0.7,4.3) to a high of 
13.8% (IQR: 11.7,16.0). In the base case scenario, the median PAF was 7.1% (IQR: 4.6,9.3).
Table 4 presents the proportions of HIV transmission events in which NG or CT infection 
were present at the site of sexual activity for one or both partners. Although these 
proportions do not indicate that NG/CT were causally related to the HIV transmission event, 
this table provides the distribution of NG/CT infection across these events. The proportion of 
transmission events in which NG or CT were present increased as the RRs for transmission 
and acquisition increased. Across the range of scenarios in which the relative risks for HIV 
transmission were varied, STI was present in one or both partners between 13.8%–28.6% of 
the time. When the relative risk for HIV acquisition was varied, STIs were present in one or 
both partners between 11.2%–21.0% of the time.
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The proportion of HIV transmission events in which the newly HIV-infected partner had 
prevalent STI at the site of sexual activity is presented in Table 5. Overall, the proportion of 
HIV transmission events in which NG and CT were both present (i.e., dual-infection) never 
exceeded 1.0%. Across the range of transmission RRs, single- or dual-infection was present 
in 11.3% to 18.3% of newly-HIV-infected partners. Across the range of acquisition relative 
risks, single- or dual-infection was present in 7.5%−16.3% of newly-HIV-infected partners.
Prevalence of NG/CT was unaffected by changes in the HIV transmission and acquisition 
RRs. Across all scenarios, prevalence of any NG infection was 1% and prevalence of any CT 
infection was 3%.
Discussion
We used agent-based modeling to estimate the potential population-level effects of highly 
prevalent bacterial STIs, NG and CT, on HIV incidence among MSM in the United States. 
We distinguished the effects of NG/CT on 1) HIV transmission from STI and HIV-infected 
men and 2) HIV acquisition by HIV-uninfected and STI-infected men. HIV incidence 
increased as the relative risks associated with HIV transmission and acquisition from an STI 
increased. Comparing a scenario in which our best estimates of the effect of NG/CT on HIV 
acquisition and transmission were in effect compared to a null condition in which there was 
no effect of NG/CT on HIV risk, we estimated that approximately 10% of HIV infections 
among MSM were attributable to NG/CT. This represents an estimate of the causal effect of 
NG/CT on HIV incidence, and therefore might represent the potential effect of a maximally 
efficient STI control intervention on HIV incidence in this population.
A difficult task in empirical studies28 has been to isolate the effects of NG/CT on HIV 
transmission versus acquisition, as we did using a simulation-based approach. Disentangling 
these is critical from a public health perspective because it implies either a targeting of STI 
screening and treatment for HIV-infected versus HIV-uninfected MSM. For example, if 
prevalent STI has a stronger effect on HIV acquisition then this would indicate that, from a 
HIV prevention perspective, that screening of HIV-uninfected MSM would be most 
effective.
Few modeling studies of MSM have simulated the co-circulation of HIV and STIs among 
MSM, and ours may be the first that does so to explicitly investigate the population-level 
impact of prevalent NG/CT on HIV incidence in this population. Other modeling studies 
have assumed a fixed set of RR parameters, despite the major uncertainty of these parameter 
values.11 There is little empirical evidence to inform these parameters, and yet, as our 
analysis shows, they have a substantial impact on the predicted HIV outcomes in modeling. 
Further, we were able to rigorously estimate the population-level effects of NG/CT by 
isolating the effects of these STIs based on sexual role and site of NG/CT infection. This 
type of data has proven to be very challenging to measure empirically because this requires 
identifying the sexual encounter that resulted in HIV infection, the sexual role(s) of each 
partner during that encounter, and the site-specific STI status of each partner. Sexual roles 
are critical for understanding the complex epidemiology of HIV/STI among MSM given the 
potential for bidirectional transmission in versatile partnerships. This concept of 
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bidirectional transmission can facilitate the speed of transmission compared with fixed-role 
heterosexual partnerships.29 Because NG and CT are typically site-specific rather than 
systemic infections, dynamic sexual roles remains a critical area for future epidemiological 
research.
Empirical data on the individual- and population-level effects of STI on HIV transmission 
and acquisition are limited. Trials and cohort studies conducted among heterosexuals in 
Africa have generally observed high prevalence of ulcerative STI.24,30,31 Different classes of 
STIs present with symptoms (e.g., ulceration) that likely affect the transmission and 
acquisition of HIV differently. Further, sexual behaviors differ markedly between 
heterosexuals and MSM, and anal sex is more prevalent among the MSM population 
compared to heterosexuals.32 Given the increased HIV transmission probabilities in rectal 
compared to vaginal sex33,34, it is likely that the effects of STI differ between heterosexual 
and MSM populations. Sexual role versatility29 and the anatomic site of the STI might affect 
the dynamics of the interaction between STI and HIV.
These estimates have critical importance for both epidemiology science and public health 
efforts aimed at disease control. For the latter, our study contributes to the evidence base 
supporting interventions for STI screening and treatment as a mechanism towards prevention 
programs on HIV incidence. We estimate the PAF of STI on HIV acquisition to be between 
2–14% and HIV transmission to be between 3–20%. Importantly, in our sensitivity analyses 
we held the effect of NG/CT on HIV transmission constant when examining RRs for HIV 
acquisition (and vice versa). Thus, these ranges might underestimate the true effect of 
NG/CT on HIV incidence if the effects we modeled underestimate the true RRs. Separately 
examining the effects of NG/CT on HIV acquisition and transmission can inform the 
potential impact of STI detection and treatment among HIV-uninfected and HIV-infected 
MSM on HIV incidence, respectively. Our overall estimate, comparing the scenario with 
acquisition and transmission RRs with the strongest evidence to a null scenario in which 
NG/CT do not affect HIV transmission or acquisition, indicates that approximately 10% of 
HIV incidence is due to NG/CT infection. This estimate corresponds to approximately 2,600 
HIV infections that could be averted annually in the United States with the immediate and 
universal elimination of NG/CT through an idealized STI control intervention.35 This sets 
the optimistic estimate sets the benchmark against which real-world interventions could be 
compared.
Limitations.
First, we estimated the PAF of NG/CT on HIV incidence using experimental scenarios with 
different prevailing RRs for HIV transmission or acquisition that were all modeled using the 
same calibrated model. This resulted in increasing population-level HIV incidence as the 
RRs increased due to increasing HIV transmission. An alternative approach would be to 
generate separate burn-in models for each of the RR combinations with the same targeted 
equilibrium HIV prevalence. However, this method would also require adjustment of other 
behavioral or biological parameters (e.g., frequency of sex acts), in order to achieve the same 
HIV prevalence across different RR scenarios. The counterfactual scenarios presented in this 
analysis provide an estimate of the proportion of HIV incidence attributable to NG and CT 
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when all other variables are held constant, analogous to an idealized STI control 
intervention. Second, the PAF values obtained in this analysis are inextricably linked to 
biological and behavioral factors. The prevalence of NG/CT, specifically the prevalence of 
NG/CT in HIV-discordant partnerships, has a direct impact on the PAF. Sexual networks 
with higher prevalence of NG/CT will have a greater proportion of HIV incidence 
attributable to NG/CT. Different levels of assortativeness, by degree or HIV/STI status, 
would also result in different PAF values, but we used a rigorous statistical analysis of 
empirical data on sexual network structure and behavior within partnerships to guide our 
base model. Our model was calibrated to national prevalence estimates of HIV. Nationally 
representative incidence rates for NG and CT are not available, so we estimated these rates 
from a cohort of MSM in Atlanta, Georgia.26,27 Third, our model did not include other STIs 
that may impact HIV transmission, such as syphilis and herpes simplex virus, which also 
share the site-specific transmission characteristics of NG and CT. Finally, the model only 
estimates the effect of anal sex. Although oral sex is negligible in estimating HIV risk, it 
does play a role in STI transmission.36 However, given our focus on the effect of NG and CT 
on HIV transmission and acquisition, the exclusion of oral sex from the model is unlikely to 
bias our results.
In conclusion, this study suggests that approximately 10% of HIV infections among MSM 
are attributable to NG/CT infection. In sensitivity analyses, we found that prevalent NG and 
CT contribute to between 2–14% of HIV acquisition and 3–20% of HIV transmissions 
among MSM. Public health strategies designed to detect and treat NG and CT among MSM 
in the United States might result in a meaningful reduction of HIV incidence among this 
high-risk population, although they must be part of a broader comprehensive strategy for 
HIV prevention that may also include consistent and correct condom use, choosing less risky 
sexual behaviors, routine testing for high-risk behaviors, drug treatment programs and using 
sterile equipment (for people who inject drugs), HIV pre-exposure prophylaxis37 for 
uninfected MSM, and treatment as prevention38−40 for HIV-infected MSM.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Acknowledgments and Funding
The authors would like to thank members of the scientific and public health advisory group of the Coalition for 
Applied Modeling for Prevention project for their input on this study, and specifically those members who reviewed 
a previous version of this manuscript: Thomas Bertrand, Mary Ann Chiasson, David Dowdy, Gregory Felzien, and 
Jonathon Poe. This work was supported by Centers for Disease Control and Prevention [grant: U38 PS004646], the 
National Institutes of Health [grants: R01 AI138783, R21 MH112449], and the Emory Center for AIDS Research 
[grant: P30 AI050409].
This work was supported by Centers for Disease Control and Prevention [grant: U38 PS004646], the National 
Institutes of Health [grants: R01 HD068395, R21 HD075662, R24 HD042828], and the Emory Center for AIDS 
Research [grant: P30 AI050409].
Jones et al. Page 8
Sex Transm Dis. Author manuscript; available in PMC 2020 June 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
References
1. Cohen MS, Hoffman IF, Royce RA, et al. Reduction of concentration of HIV-1 in semen after 
treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP 
Malawi Research Group. Lancet. 1997;349(9069):1868–1873. [PubMed: 9217758] 
2. Celum C, Wald A, Hughes J, et al. Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 
seropositive women and men who have sex with men: a randomised, double-blind, placebo-
controlled trial. Lancet. 2008;371(9630):2109–2119. [PubMed: 18572080] 
3. Celum C, Wald A, Lingappa JR, et al. Acyclovir and transmission of HIV-1 from persons infected 
with HIV-1 and HSV-2. N Engl J Med. 2010;362(5):427–439. [PubMed: 20089951] 
4. Johnson LF, Lewis DA. The effect of genital tract infections on HIV-1 shedding in the genital tract: 
a systematic review and meta-analysis. Sex Transm Dis. 2008;35(11):946–959. [PubMed: 
18685546] 
5. Moss GB, Overbaugh J, Welch M, et al. Human immunodeficiency virus DNA in urethral secretions 
in men: association with gonococcal urethritis and CD4 cell depletion. J Infect Dis. 1995;172(6):
1469–1474. [PubMed: 7594704] 
6. Rieg G, Butler DM, Smith DM, Daar ES. Seminal plasma HIV levels in men with asymptomatic 
sexually transmitted infections. Int J STD AIDS. 2010;21(3):207–208. [PubMed: 20215629] 
7. Winter AJ, Taylor S, Workman J, et al. Asymptomatic urethritis and detection of HIV-1 RNA in 
seminal plasma. Sex Transm Infect. 1999;75(4):261–263. [PubMed: 10615314] 
8. Davies O, Costelloe S, Cross G, et al. Impact of rectal gonorrhoea and chlamydia on HIV viral load 
in the rectum: potential significance for onward transmission. Int J STD AIDS. 2017;28(10):1034–
1037. [PubMed: 28081680] 
9. Grosskurth H, Gray R, Hayes R, Mabey D, Wawer M. Control of sexually transmitted diseases for 
HIV-1 prevention: understanding the implications of the Mwanza and Rakai trials. Lancet. 
2000;355(9219):1981–1987. [PubMed: 10859054] 
10. Barnabas RV, Wasserheit JN. Riddle of the Sphinx revisited: the role of STDs in HIV prevention. 
Sex Transm Dis. 2009;36(6):365–367. [PubMed: 19434009] 
11. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: 
the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex 
Transm Infect. 1999;75(1):3–17. [PubMed: 10448335] 
12. Koblin BA, Husnik MJ, Colfax G, et al. Risk factors for HIV infection among men who have sex 
with men. AIDS. 2006;20(5):731–739. [PubMed: 16514304] 
13. Castillo R, Konda KA, Leon SR, et al. HIV and sexuallyt transmitted infection incidence and 
associated risk factors among high-risk MSM and male-to-female transgender women in Lima, 
Peru. J Acquir Immune Defic Syndr. 2015;69(5):567–575. [PubMed: 25950207] 
14. Bernstein KT, Marcus JL, Nieri G, Philip SS, Klausner JD. Rectal gonorrhea and chlamydia 
reinfection is associated with increased risk of HIV seroconversion. J Acquir Immune Defic Syndr. 
2010;53(4):537–543. [PubMed: 19935075] 
15. Jenness SM, Goodreau SM, Morris M. EpiModel: An R package for mathematical modeling of 
infectious disease over networks. Journal of statistical software. 2018;84(8).
16. Jenness SM, Weiss KM, Goodreau SM, et al. Incidence of gonorrhea and chlamydia following 
human immunodeficiency virus preexposure prophylaxis among men who have sex with men: A 
modeling study. Clin Infect Dis. 2017;65(5):712–718. [PubMed: 28505240] 
17. Sullivan PS, Rosenberg ES, Sanchez TH, et al. Explaining racial disparities in HIV incidence in 
black and white men who have sex with men in Atlanta, GA: a prospective observational cohort 
study. Ann Epidemiol. 2015;25(6):445–454. [PubMed: 25911980] 
18. Hernandez-Romieu AC, Sullivan PS, Rothenberg R, et al. Heterogeneity of HIV prevalence among 
the sexual networks of black and white men who have sex with men in Atlanta: Illuminating a 
mechanism for increased HIV risk for young black men who have sex with men. Sex Transm Dis. 
2015;42(9):505–512. [PubMed: 26267877] 
19. Wilson DP, Law MG, Grulich AE, Cooper DA, Kaldor JM. Relation between HIV viral load and 
infectiousness: a model-based analysis. Lancet. 2008;372(9635):314–320. [PubMed: 18657710] 
Jones et al. Page 9
Sex Transm Dis. Author manuscript; available in PMC 2020 June 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
20. Marmor M, Sheppard HW, Donnell D, Bozeman S, Celum C. Homozygous and heterozygous 
CCR5-[delta]32 genotypes are associated with resistance to HIV infection. JAIDS Journal of 
Acquired Immune Deficiency Syndromes. 2001;27(5):472–481. [PubMed: 11511825] 
21. Smith DK, Herbst JH, Zhang X, Rose CE. Condom effectiveness for HIV prevention by 
consistency of use among men who have sex with men in the United States. J Acquir Immune 
Defic Syndr. 2015;68(3):337–344. [PubMed: 25469526] 
22. Goodreau SM, Carnegie NB, Vittinghoff E, et al. What drives the US and Peruvian HIV epidemics 
in men who have sex with men (MSM)? PLoS One. 2012;7(11):e50522. [PubMed: 23209768] 
23. Wiysonge CS, Kongnyuy EJ, Shey M, et al. Male circumcision for prevention of homosexual 
acquisition of HIV in men. The Cochrane database of systematic reviews. 2011(6):CD007496. 
[PubMed: 21678366] 
24. Wall KM, Kilembe W, Vwalika B, et al. Risk of heterosexual HIV transmission attributable to 
sexually transmitted infections and non-specific genital inflammation in Zambian discordant 
couples, 1994–2012. Int J Epidemiol. 2017;46(5):1593–1606. [PubMed: 28402442] 
25. Rosenberg ES, Grey JA, Sanchez TH, Sullivan PS. Rates of prevalent HIV infection, prevalent 
diagnoses, and new diagnoses among men who have sex with men in US states, metropolitan 
statistical areas, and counties, 2012–2013. JMIR Public Health Surveill. 2016;2(1):e22. [PubMed: 
27244769] 
26. Kelley CF, Vaughan AS, Luisi N, et al. The effect of high rates of bacterial sexually transmitted 
infections on HIV incidence in a cohort of black and white men who have sex with men in Atlanta, 
Georgia. AIDS Res Hum Retroviruses. 2015;31(6):587–592. [PubMed: 25719950] 
27. Stenger MR, Pathela P, Anschuetz G, et al. Increases in the rate of Neisseria gonorrhoeae among 
gay, bisexual and other men who have sex with men-Findings from the Sexually Transmitted 
Disease Surveillance Network 2010–2015. Sex Transm Dis. 2017;44(7):393–397. [PubMed: 
28608788] 
28. Orroth KK, White RG, Korenromp EL, et al. Empirical observations underestimate the proportion 
of human immunodeficiency virus infections attributable to sexually transmitted diseases in the 
Mwanza and Rakai sexually transmitted disease treatment trials: Simulation results. Sex Transm 
Dis. 2006;33(9):536–544. [PubMed: 16778738] 
29. Goodreau SM, Golden MR. Biological and demographic causes of high HIV and sexually 
transmitted disease prevalence in men who have sex with men. Sex Transm Infect. 2007;83(6):
458–462. [PubMed: 17855487] 
30. Grosskurth H, Mosha F, Todd J, et al. Impact of improved treatment of sexually transmitted 
diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet. 1995;346(8974):
530–536. [PubMed: 7658778] 
Jones et al. Page 10
Sex Transm Dis. Author manuscript; available in PMC 2020 June 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Jones et al. Page 11
Table 1.
Relative risks (RRs) for HIV transmission and acquisition based on site of STI across modeled scenarios.
Relative Risk of Transmission Analysis
Transmission RRs Acquisition RRs
Gonorrhea Chlamydia Rectal Urethral
Current base case scenario; Referent for HIV Transmission Analysis 1.0 1.0 1.97 1.48
1.0 2.0 1.97 1.48
1.0 3.0 1.97 1.48
2.0 1.0 1.97 1.48
2.0 2.0 1.97 1.48
2.0 3.0 1.97 1.48
3.0 1.0 1.97 1.48
3.0 2.0 1.97 1.48
3.0 3.0 1.97 1.48
Relative Risk of Acquisition Analysis
Transmission RRs Acquisition RRs
Gonorrhea Chlamydia Rectal Urethral
Base case acquisition RRs 1.3 1.3 1.97 1.48
Referent for HIV Acquisition Analysis 1.3 1.3 1.0 1.0
1.3 1.3 1.0 2.0
1.3 1.3 1.0 3.0
1.3 1.3 2.0 1.0
1.3 1.3 2.0 2.0
1.3 1.3 2.0 3.0
1.3 1.3 3.0 1.0
1.3 1.3 3.0 2.0
1.3 1.3 3.0 3.0
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Table 2.
The effect of relative risk for HIV transmission on HIV incidence.
Relative Risk of HIV Transmission by STI HIV Incidence Rate Population Attributable Fraction
Gonorrhea Chlamydia Rate per 100 PYAR1 (IQR) % (IQR)
1.0 1.0 1.90 (1.86, 1.94) Ref2
1.0 2.0 2.02 (1.97, 2.06) 5.9 (3.4, 7.9)
1.0 3.0 2.13 (2.08, 2.18) 10.7 (8.6, 12.9)
2.0 1.0 1.96 (1.91, 2.00) 3.1 (0.5, 5.2)
2.0 2.0 2.11 (2.06, 2.16) 10.1 (8.0, 12.2)
2.0 3.0 2.27 (2.21, 2.33) 16.2 (14.1, 18.5)
3.0 1.0 2.01 (1.96, 2.05) 5.6 (3.0, 7.5)
3.0 2.0 2.18 (2.11, 2.24) 12.8 (10.2, 15.1)
3.0 3.0 2.39 (2.31, 2.45) 20.4 (17.8, 22.5)
1
Person years at risk;
2
Base case scenario; HIV acquisition relative risks were held constant at base case values, rectal RR = 1.97, urethral RR = 1.48.
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Table 3.
The effect of relative risk for HIV acquisition on HIV incidence
Relative Risk of HIV Acquisition by STI Anatomic Site HIV Incidence Rate Population Attributable Fraction
Rectal Urethral Rate per 100 PYAR* (IQR) % (IQR)
1.97 1.48 1.96 (1.91, 2.01) 7.1 (4.6, 9.3)
1.0 1.0 1.83 (1.78, 1.87) Ref
1.0 2.0 1.86 (1.81, 1.91) 2.0 (−0.7, 4.3)
1.0 3.0 1.89 (1.84, 1.93) 3.2 (0.8, 5.3)
2.0 1.0 1.93 (1.89, 1.98) 5.6 (3.6, 7.8)
2.0 2.0 1.98 (1.94, 2.02) 7.7 (5.9, 9.8)
2.0 3.0 2.00 (1.95, 2.04) 8.6 (6.4, 10.7)
3.0 1.0 2.02 (1.97, 2.07) 9.6 (7.4, 11.9)
3.0 2.0 2.07 (2.03, 2.12) 12.0 (10.0, 13.9)
3.0 3.0 2.12 (2.07, 2.17) 13.8 (11.7, 16.0)
*
Person years at risk; HIV transmission relative risks were held constant at rectal RR = 1.3 and urethral RR = 1.3.
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Table 4.
Proportion of transmission events in which site- and role-specific rectal and/or urethral STI were present.
Relative Risk of HIV Transmission by STI
Anatomic Sites of Sexual Activity with Prevalent STI
Median (IQR) Proportion of Transmission Events
Gonorrhea Chlamydia Rectal and Urethral Rectal Only Urethral Only Neither
1.0 1.0 6.6 (6.3, 7.0) 5.4 (5.1, 5.9) 2.7 (2.4, 3.0) 85.3 (84.1, 86.2)
1.0 2.0 8.7 (8.4, 9.2) 5.5 (5.1, 5.8) 4.0 (3.6, 4.2) 81.9 (80.8, 83.0)
1.0 3.0 10.2 (9.8, 10.5) 5.5 (5.2, 5.9) 4.9 (4.6, 5.2) 79.3 (78.4, 80.4)
2.0 1.0 7.6 (7.1, 7.9) 5.6 (5.2, 6.0) 3.1 (2.8, 3.3) 83.7 (82.8, 84.8)
2.0 2.0 10.1 (9.8, 10.6) 6.2 (5.8, 6.5) 4.5 (4.1, 4.8) 79.2 (78.1, 80.3)
2.0 3.0 12.0 (11.7, 12.3) 6.8 (6.5, 7.2) 5.7 (5.4, 6.0) 75.4 (74.5, 76.4)
3.0 1.0 8.5 (8.1, 8.9) 6.1 (5.7, 6.2) 3.4 (3.1, 3.8) 82.0 (81.1, 83.0)
3.0 2.0 11.1 (10.7, 11.4) 6.8 (6.5, 7.2) 5.0 (4.7, 5.3) 77.1 (76.1, 78.1)
3.0 3.0 13.0 (12.8, 13.3) 7.9 (7.7, 8.2) 6.6 (6.4, 7.0) 72.4 (71.4, 73.2)
Relative Risk of HIV Acquisition by STI Anatomic Site
Anatomic Sites of Sexual Activity with Prevalent STI
Median (IQR) Proportion of Transmission Events
Rectal Urethral Rectal and Urethral Rectal Only Urethral Only Neither
1.97 1.48 7.4 (7.1, 7.7) 5.4 (5.0, 5.7) 3.0 (2.8, 3.3) 84.2 (83.3, 85.1)
1.0 1.0 4.7 (4.3, 5.0) 3.6 (3.2, 3.9) 2.9 (2.5, 3.2) 88.8 (87.9, 89.9)
1.0 2.0 5.2 (4.8, 5.5) 4.0 (3.6, 4.2) 3.3 (2.9, 3.6) 87.6 (86.6, 88.6)
1.0 3.0 5.9 (5.6, 6.2) 4.5 (4.1, 4.8) 3.7 (3.3, 4.0) 85.9 (85, 86.9)
2.0 1.0 6.8 (6.6, 7.2) 5.0 (4.6, 5.3) 2.8 (2.5, 3.1) 85.4 (84.3, 86.3)
2.0 2.0 7.8 (7.5, 8.1) 5.6 (5.3, 5.9) 3.3 (3.0, 3.6) 83.3 (82.4, 84.3)
2.0 3.0 8.3 (7.9, 8.6) 6.0 (5.6, 6.3) 3.6 (3.3, 3.8) 82.2 (81.2, 83.2)
3.0 1.0 8.5 (8.2, 8.8) 6.1 (5.8, 6.4) 2.8 (2.6, 3.1) 82.6 (81.6, 83.3)
3.0 2.0 9.4 (9.1, 9.8) 6.7 (6.3, 7.0) 3.2 (2.9, 3.4) 80.6 (79.8, 81.7)
3.0 3.0 10.2 (9.7, 10.5) 7.3 (7.1, 7.5) 3.6 (3.3, 3.8) 79.0 (78.2, 79.9)
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Table 5.
Proportion of transmission events in which the newly HIV-infected partner had site- and role-specific 
gonorrhea and/or chlamydia.
Relative Risk of HIV Transmission by STI
STI Status of Newly HIV-Infected Partner
Median (IQR) Proportion of Transmission Events
Gonorrhea Chlamydia Gonorrhea and Chlamydia Gonorrhea Only Chlamydia Only Neither
1.0 1.0 0.3 (0.2, 0.6) 3.0 (2.7, 3.3) 7.9 (7.5, 8.3) 88.7 (87.8, 89.5)
1.0 2.0 0.4 (0.3, 0.6) 3.1 (2.8, 3.4) 9.8 (9.3, 10.2) 86.7 (85.7, 87.6)
1.0 3.0 0.5 (0.4, 0.7) 3.3 (3.0, 3.6) 10.9 (10.5, 11.3) 85.2 (84.4, 86.1)
2.0 1.0 0.4 (0.3, 0.7) 4.0 (3.7, 4.3) 7.6 (7.2, 8.0) 87.9 (87.0, 88.7)
2.0 2.0 0.6 (0.6, 0.9) 4.5 (4.1, 4.8) 9.6 (9.3, 10.0) 85.3 (84.3, 86.1)
2.0 3.0 0.9 (0.7, 1.1) 4.8 (4.5, 5.1) 11.2 (10.8, 11.6) 83.1 (82.3, 84.0)
3.0 1.0 0.6 (0.3, 0.7) 4.9 (4.4, 5.1) 7.8 (7.6, 8.3) 86.7 (85.8, 87.7)
3.0 2.0 0.8 (0.6, 1.0) 5.3 (5.0, 5.7) 9.8 (9.5, 10.1) 84.0 (83.2, 84.9)
3.0 3.0 1.0 (0.8, 1.2) 5.9 (5.6, 6.3) 11.4 (11.0, 11.7) 81.7 (80.8, 82.7)
Relative Risk of HIV Acquisition by STI Anatomic 
Site
STI Status of Newly HIV-Infected Partner
Median (IQR) Proportion of Transmission Events
Rectal Urethral Gonorrhea and Chlamydia Gonorrhea Only Chlamydia Only Neither
1.97 1.48 0.4 (0.2, 0.5) 3.4 (3.0, 3.7) 8.0 (7.7, 8.3) 88.2 (87.4, 89.1)
1.0 1.0 0.2 (0.1, 0.3) 2.2 (1.9, 2.4) 5.1 (4.7, 5.5) 92.5 (91.8, 93.3)
1.0 2.0 0.2 (0.1, 0.3) 2.2 (2.0, 2.5) 5.8 (5.4, 6.2) 91.7 (91, 92.5)
1.0 3.0 0.4 (0.2, 0.5) 2.7 (2.3, 2.9) 6.4 (6.2, 6.9) 90.5 (89.7, 91.3)
2.0 1.0 0.3 (0.2, 0.4) 3.1 (2.7, 3.3) 7.7 (7.3, 8.0) 88.9 (88.3, 89.8)
2.0 2.0 0.4 (0.3, 0.6) 3.5 (3.1, 3.8) 8.6 (8.2, 8.9) 87.5 (86.7, 88.4)
2.0 3.0 0.4 (0.3, 0.6) 3.6 (3.3, 3.9) 9.1 (8.7, 9.5) 86.8 (86, 87.7)
3.0 1.0 0.4 (0.3, 0.5) 3.7 (3.4, 4.1) 9.6 (9.2, 9.9) 86.3 (85.5, 87)
3.0 2.0 0.5 (0.3, 0.6) 4.2 (3.9, 4.4) 10.4 (10.1, 10.9) 84.9 (84.1, 85.7)
3.0 3.0 0.5 (0.4, 0.7) 4.5 (4.2, 4.8) 11.3 (10.8, 11.7) 83.7 (82.8, 84.5)
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